Response of BRCA1-mutated gallbladder cancer to olaparib: A case report

doi:10.3748/wjg.v22.i46.10254

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 46

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7359)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series.

Item

Count

PDF

452

WORD

197

HTML

3923

Figures (1-6)

159

Sum=4731

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

916

Download

1712

Sum=2628

Dec 14, 2016 (publication date) through May 6, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Dec 14, 2016; 22(46): 10254-10259
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10254

Full Size Figure Download Figure

Figure 4 Baseline (July 21, 2015) computed tomography of the abdomen revealed many intra- and extra-hepatic lesions before initiating olaparib treatment.

Citation: Xie Y, Jiang Y, Yang XB, Wang AQ, Zheng YC, Wan XS, Sang XT, Wang K, Zhang DD, Xu JJ, Li FG, Zhao HT. Response of BRCA1-mutated gallbladder cancer to olaparib: A case report. World J Gastroenterol 2016; 22(46): 10254-10259
URL: https://www.wjgnet.com/1007-9327/full/v22/i46/10254.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i46.10254